Page 1 1 Origins of Breast Density Legislation Origins of Breast - - PDF document

page 1
SMART_READER_LITE
LIVE PREVIEW

Page 1 1 Origins of Breast Density Legislation Origins of Breast - - PDF document

Message Breast Density Notification Legislation, The majority of states have enacted breast density notification legislation. Supplemental Screening and Controversies A basic understanding of the implications of Amie Y. Lee, MD dense breast


slide-1
SLIDE 1

1

Page 1

Breast Density Notification Legislation, Supplemental Screening and Controversies

Amie Y. Lee, MD Assistant Professor, Breast Imaging University of California, San Francisco

1

Message

The majority of states have enacted breast density notification legislation. A basic understanding of the implications of dense breast tissue and supplemental screening

  • ptions will allow you to better communicate

with your patients.

2

Outline

  • Origins of breast density legislation and

current status.

  • What is breast density?
  • Why is it important?
  • What to do about it?

3

Outline

  • Origins of breast density legislation and

current status.

  • What is breast density?
  • Why is it important?
  • What to do about it?

4

slide-2
SLIDE 2

2

Page 2

http://areyoudense.org

  • In 2003, Nancy Capello had a

negative screening mammogram

  • 6 weeks later, a palpable lump

was detected on CBE

– A 2.5 cm mass was found on US – Stage IIIC cancer with metastasis to 13 axillary lymph nodes

  • She learned for the first time that

she had dense breast tissue

Origins of Breast Density Legislation

Image use with permission by Dr. Nancy Capello

5

Origins of Breast Density Legislation

  • She believed her cancer would have been diagnosed

earlier had she been informed of her breast density and undergone supplemental screening

  • Capello lobbied for state legislation to inform women of

dense breasts

– In 2009, the first breast density notification law passed in her state of CT

6

Origins of Breast Density Legislation

  • She founded ‘Are You Dense Advocacy, Inc to advance

legislation in other states

Image use with permission by Dr. Nancy Capello (http://areyoudense.org)

7

Origins of Breast Density Legislation

Her story and the issue of breast density has received widespread national attention

8

slide-3
SLIDE 3

3

Page 3

2009: CT is the 1st state to pass breast density notification legislation

9

2012: CA becomes the 5th state to pass breast density notification legislation

10

2018: 35 states require breast density notification An additional 3 states recommend it

11

Federal Efforts:

densebreast-info.org

12

slide-4
SLIDE 4

4

Page 4

California Breast Density Legislation

  • Effective as of April 1, 2013
  • Exact wording specified by law
  • 13

California Breast Density Legislation

“Your mammogram shows that your breast tissue is

  • dense. Dense breast tissue is common and is not
  • abnormal. However, dense breast tissue can make it

harder to evaluate the results of your mammogram and may also be associated with an increased risk of breast cancer. This information about the results of your mammogram is given to you to raise your awareness and to inform your conversations with your doctor. Together, you can decide which screening options are right for you.”

14

Outline

  • Origins of breast density legislation and

current status in the U.S.

  • What is breast density?
  • Why is it important?
  • What to do about it?

15

Breast Density Assessment

  • Density = Relative amount of fibroglandular

tissue is within the breast

  • Based on qualitative visual assessment of

mammogram by the radiologist

– Indicate the relative possibility that a lesion could be obscured by normal tissue

16

slide-5
SLIDE 5

5

Page 5

Four Breast Composition Categories ACR BI-RADS 5th ed. 2013

  • A. The breasts are almost entirely fatty
  • B. There are scattered areas of fibroglandular

density

  • C. The breasts are heterogeneously dense,

which may obscure small masses

  • D. The breasts are extremely dense, which

lowers the sensitivity of mammography

17

(A) Fatty (B) Scattered (C) Heterogeneous

Breast Density Categories

(D) Extreme

18

(A) Fatty (B) Scattered (D) Extreme

~50% have dense breast tissue

(C) Heterogeneous

Distribution of patients by density

Breast density policies impact approximately half the screening population à Wide ranging consequences

19

Outline

  • Origins of breast density legislation and

current status in the U.S.

  • What is breast density?
  • Why is it important?
  • What to do about it?

20

slide-6
SLIDE 6

6

Page 6

What is the Clinical Significance of Mammographic Breast Density?

  • Masking

– Dense tissue can mask cancers on mammography

  • Risk

– Presence of dense tissue is a risk factor for the development of breast cancer

21

Masking

22 23 24

slide-7
SLIDE 7

7

Page 7

25 26 27

Masking Associated with Breast Density

How much does dense breast tissue reduce the sensitivity

  • f mammography?
  • Overall ~ 10% decreased sensitivity

28

slide-8
SLIDE 8

8

Page 8

Risk Associated with Breast Density

  • Risk of breast cancer increases with increasing breast

density

  • Average density at screening is between B & C

– RR for density C vs. “average”: 1.2 – RR for density D vs. “average”: 2.1

  • Women with density D have a 4-6 x increased risk of

breast cancer compared to women with density A

29

  • Breast density is an independent risk factor but not a

major one.

densebreast-info.org

30

Outline

  • Origins of breast density legislation and

current status in the U.S.

  • What is breast density?
  • Why is it important?
  • What to do about it?

31

Key Point

Mammography is the only screening tool shown to reduce breast cancer mortality in randomized controlled trials

32

slide-9
SLIDE 9

9

Page 9

Any supplementary screening is in addition to (not instead of) screening mammography Decision to pursue supplemental screening is an informed personal decision, including discussion of other risk factors

Imaging Options for Suppl Screening

33

  • Breast MRI
  • Whole Breast Ultrasound

− Hand-held (HHUS) − Automated (ABUS)

  • Breast Tomosynthesis

Imaging Options for Suppl Screening

34

  • Not limited by dense breast tissue
  • Most sensitive modality for detecting breast

cancer

  • Recommended for screening high risk

women (>20-25% lifetime risk)

Breast MRI

35

Limitations:

  • Limited specificity (increased false positives)
  • Requires IV contrast
  • Length of exam
  • Expensive

Breast MRI

36

slide-10
SLIDE 10

10

Page 10

Breast MRI

Small mass in dense breast tissue

37

Spiculated enhancing mass

Invasive Ductal Carcinoma

Breast MRI 38

  • Finds additional cancers not seen at mammography
  • Well tolerated by patients
  • Less expensive, less invasive than MRI

Whole Breast Ultrasound

39

Limitations:

  • Very poor specificity
  • Very high false positive recall and biopsy rate
  • >90% of biopsies are not malignant

Breast Ultrasound Screening

40

slide-11
SLIDE 11

11

Page 11

  • Studies to date are promising

− Cancer detection similar to US, lower than MRI − Fewer false positives than US − Most studies: improved sensitivity + specificity

Breast Tomosynthesis (DBT)

41

Limitations

  • Limited availability
  • Added time (but less than MRI and US)
  • Additional radiation (but within FDA limits)

Due to promising initial results, DBT is slowly being incorporated into the standard annual screening mammogram

Tomosynthesis (DBT)

42

Screening

43

Tomosynthesis (DBT)

44

slide-12
SLIDE 12

12

Page 12

Breast Density Legislation: Problems

  • Insurance coverage for supplemental screening

not guaranteed

− < 10 states mandate insurance coverage

  • US and MRI increase false positives
  • No evidence of mortality benefit…yet

45

Additional guidance?

46

DenseBreast-info.org

  • Educational resource providing information on breast

density to patients and health care providers

47

What do we offer at UCSF?

  • Screening mammography
  • Supplemental screening based on risk
  • If high risk (>20% lifetime risk), add MRI
  • US screening not offered at UCSF
  • DBT- Women may opt for this as part of routine

screening mammography exam

  • Supplemental screening: Insurance coverage is not

guaranteed

48

slide-13
SLIDE 13

13

Page 13

Summary

  • ~ 50% of women undergoing screening

mammography have dense breast tissue

  • Dense breast tissue decreases the sensitivity of

mammography by masking

  • Dense breast tissue is an independent cancer risk

factor

49

Summary

  • No consensus for supplemental screening
  • Screening US improves cancer detection
  • MRI has the highest cancer detection
  • Both US and MRI have limited specificity
  • Initial data on the performance of DBT is

encouraging Mammography is the only screening tool shown to reduce breast cancer mortality in randomized controlled trials

50

Thank you!

Amie.Lee2@ucsf.edu

51